Audentes Therapeutics, Inc. Contracts & Agreements
56 Contracts & Agreements
- Business Finance (9 contracts)
- Business Operations (6)
- Human Resources (15)
- Intellectual Property (7)
- Mergers & Acquisitions (1)
- Real Estate (13)
- Uncategorized (5)
- Retention Agreement between the Company and Matthew Patterson, dated November 30, 2019 (Filed With SEC on December 3, 2019)
- Retention Agreement between the Company and Natalie Holles, dated November 30, 2019 (Filed With SEC on December 3, 2019)
- Retention Agreement between the Company and Thomas Soloway, dated November 30, 2019 (Filed With SEC on December 3, 2019)
- Agreement and Plan of Merger, dated as of December 2, 2019, by and among Astellas Pharma Inc., Asilomar Acquisition Corp., and Audentes Therapeutics, Inc (Filed With SEC on December 3, 2019)
- 2016 Equity Incentive Plan (Filed With SEC on November 7, 2019)
- 2016 Equity Incentive forms of award agreements (Filed With SEC on November 7, 2019)
- 2018 Equity Inducement forms of award agreements (Filed With SEC on November 7, 2019)
- Separation Letter Agreement, executed May 30, 2019, by and between the Registrant and John Gray (Filed With SEC on August 7, 2019)
- Separation Letter Agreement, executed June 25, 2019, by and between the Registrant and Suyash Prasad (Filed With SEC on August 7, 2019)
- Form of Restricted Stock Unit Award Agreement for 2018 Equity Inducement Plan (Filed With SEC on March 1, 2019)
- Net Commercial Lease, dated August 15, 2018, by and between the Registrant and JCN Partners (Filed With SEC on November 7, 2018)
- First Amendment dated September 30, 2018, to Net Commercial Lease, effective June 1, 2017, by and between the Registrant and JCN Partners (Filed With SEC on November 7, 2018)
- Executive Employment Agreement, effective September 19, 2018, by and between the Registrant and Natalie Holles (Filed With SEC on November 7, 2018)
- Underwriting Agreement dated October 10, 2018 (Filed With SEC on October 11, 2018)
- Form of Executive Employment Agreement (Filed With SEC on March 9, 2018)
- First Amendment to License Agreement, dated November 3, 2017, by and between the Registrant and REGENXBIO Inc. (relating to CPVT) (Filed With SEC on March 9, 2018)
- Fourth Amendment to Exclusive License and Collaboration Agreement, effective December 20, 2017, by and between the Registrant and The Trustees of the University of Pennsylvania (Filed With SEC on March 9, 2018)
- Underwriting Agreement dated January 24, 2018 (Filed With SEC on January 25, 2018)
- BRITANNIA GATEWAY BUSINESS PARK LEASE (Filed With SEC on August 10, 2017)
- AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on August 10, 2017)
- THIRD AMENDMENT TO EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on August 10, 2017)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 5, 2017)
- AUDENTES THERAPEUTICS, INC. (aDelaware corporation) [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 17, 2017)
- 101 MontgomeryStreet Suite 2650 San Francisco CA 94104 USA www.audentestx.com (Filed With SEC on April 10, 2017)
- 101 MontgomeryStreet Suite 2650 San Francisco CA 94104 USA www.audentestx.com (Filed With SEC on April 10, 2017)
- SECONDAMENDMENT TO EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on April 3, 2017)
- WARRANT AGREEMENT To Purchase Shares of the Common Stock of AUDENTES THERAPEUTICS, INC. Dated as of March 7, 2017 (the Effective Date) (Filed With SEC on March 13, 2017)
- NET COMMERCIAL LEASE (Filed With SEC on March 13, 2017)
- NET COMMERCIAL LEASE (Filed With SEC on March 13, 2017)
- FIRST AMENDMENT TO LEASE AGREEMENT Property Address: 550-3 Eccles Avenue South San Francisco, California (Filed With SEC on March 13, 2017)
- FIRST AMENDMENT TO OFFICE LEASE (Filed With SEC on March 13, 2017)
- FIRST AMENDMENT TO EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on March 13, 2017)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on March 13, 2017)
- AUDENTES THERAPEUTICS, INC. (a Delaware corporation) [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on July 11, 2016)
- INDEMNITY AGREEMENT (Filed With SEC on July 11, 2016)
- AUDENTES THERAPEUTICS, INC. 2016 EQUITY INCENTIVE PLAN (Filed With SEC on July 11, 2016)
- AUDENTES THERAPEUTICS, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on July 11, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 11, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 11, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 11, 2016)
- CONSENT TO SUBLEASE AGREEMENT (Filed With SEC on June 16, 2016)
- NET COMMERCIAL LEASE (Filed With SEC on June 16, 2016)
- EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on June 16, 2016)
- FIRST AMENDMENT TO LICENSE AGREEMENT NO. A13169 (Filed With SEC on June 16, 2016)
- OFFICE LEASE BY ANDBETWEEN 101 MONTGOMERY STREET CO., a California limited partnership AS LANDLORD AND AUDENTES THERAPEUTICS, INC., a Delaware corporation AS TENANT PREMISES: 101... (Filed With SEC on March 9, 2016)
- AUDENTESTHERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on January 4, 2016)
- AUDENTES THERAPEUTICS, INC. 2012 EQUITY INCENTIVE PLAN As Adopted on December 21, 2012 (Filed With SEC on January 4, 2016)
- OFFICE LEASE BY ANDBETWEEN 101 MONTGOMERY STREET CO., a California limited partnership AS LANDLORD AND AUDENTES THERAPEUTICS, INC., a Delaware corporation AS TENANT PREMISES: 101... (Filed With SEC on January 4, 2016)
- SUBLEASE (Filed With SEC on January 4, 2016)
- OFFICE LEASE (Filed With SEC on January 4, 2016)
- COLLABORATIVE DEVELOPMENT AGREEMENT No. 013135-1MTUB-00 (Filed With SEC on January 4, 2016)
- LICENSE AGREEMENT (Filed With SEC on January 4, 2016)
- EXCLUSIVE LICENSE AGREEMENT WITH KNOW-HOW Agreement No: A13169 TABLE OF CONTENTS (Filed With SEC on January 4, 2016)
- LICENSE AGREEMENT (Filed With SEC on January 4, 2016)
- LICENSE AGREEMENT (Filed With SEC on January 4, 2016)
- LICENSEAGREEMENT (Filed With SEC on January 4, 2016)